Latest news with #SuzhouSunmun
Yahoo
22-07-2025
- Business
- Yahoo
Asian Growth Companies With Strong Insider Ownership In July 2025
As of July 2025, Asian markets are navigating a complex landscape marked by mixed economic signals and geopolitical developments. While China's growth has eased pressure for immediate stimulus, concerns about deflation and property market weakness linger, influencing investor sentiment across the region. In such an environment, companies with high insider ownership often attract attention as they may signal confidence from those closest to the business. Top 10 Growth Companies With High Insider Ownership In Asia Name Insider Ownership Earnings Growth Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 61% Vuno (KOSDAQ:A338220) 15.6% 109.8% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Shanghai Huace Navigation Technology (SZSE:300627) 24.3% 23.5% Oscotec (KOSDAQ:A039200) 12.7% 98.7% Novoray (SHSE:688300) 23.6% 28.2% M31 Technology (TPEX:6643) 30.8% 63.4% Laopu Gold (SEHK:6181) 35.5% 42.6% Gold Circuit Electronics (TWSE:2368) 31.4% 25.9% Fulin Precision (SZSE:300432) 13.6% 43.7% Click here to see the full list of 589 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Below we spotlight a couple of our favorites from our exclusive screener. Ascentage Pharma Group International Simply Wall St Growth Rating: ★★★★★☆ Overview: Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing therapies for cancers, chronic hepatitis B virus, and age-related diseases in Mainland China, with a market cap of HK$26.61 billion. Operations: The company's revenue segment includes the development and sale of novel small-scale therapies, generating CN¥980.65 million. Insider Ownership: 13.5% Earnings Growth Forecast: 62.9% p.a. Ascentage Pharma Group International, a growth-focused company in Asia with substantial insider ownership, recently completed a HK$1.51 billion equity offering to support its expansion. The company has achieved significant milestones with the approval of lisaftoclax for CLL/SLL treatment in China and ongoing global Phase III trials. Despite being currently unprofitable, Ascentage is projected to see revenue grow 23.2% annually and become profitable within three years, driven by innovative drug developments like lisaftoclax and olverembatinib. Get an in-depth perspective on Ascentage Pharma Group International's performance by reading our analyst estimates report here. Our expertly prepared valuation report Ascentage Pharma Group International implies its share price may be too high. Shanghai Putailai New Energy TechnologyLtd Simply Wall St Growth Rating: ★★★★☆☆ Overview: Shanghai Putailai New Energy Technology Co., Ltd. develops and sells lithium-ion battery materials and automation equipment in China, with a market cap of CN¥38.81 billion. Operations: The company generates revenue from the development and sale of materials for lithium-ion batteries and automation equipment within China. Insider Ownership: 37% Earnings Growth Forecast: 28.9% p.a. Shanghai Putailai New Energy Technology Ltd. is experiencing robust earnings growth, forecasted at 28.9% annually, outpacing the Chinese market average of 23.4%. Despite recent removal from major indices like SSE 180, it trades below estimated fair value and shows strong relative value against peers. Revenue growth is projected at a slower pace of 15.4%, yet still above the market's average. The company maintains an unstable dividend track record but recently announced a CNY 0.17 per share dividend payout. Dive into the specifics of Shanghai Putailai New Energy TechnologyLtd here with our thorough growth forecast report. Our comprehensive valuation report raises the possibility that Shanghai Putailai New Energy TechnologyLtd is priced lower than what may be justified by its financials. SICC Simply Wall St Growth Rating: ★★★★★☆ Overview: SICC Co., Ltd. is involved in the research, development, production, and sale of silicon carbide semiconductor materials both in China and internationally, with a market cap of CN¥25.38 billion. Operations: The company's revenue primarily comes from its semiconductor material segment, which generated CN¥1.75 billion. Insider Ownership: 30.2% Earnings Growth Forecast: 35.6% p.a. SICC Co., Ltd. is experiencing substantial growth, with earnings expected to rise significantly at 35.6% annually, surpassing the Chinese market's average growth rate of 23.4%. Revenue is projected to grow at a robust 21.4% per year, well above the market's 12.5%. Despite a recent decline in net income and revenue compared to last year, insider ownership remains high, reflecting strong internal confidence in future prospects amid strategic financial maneuvers approved by shareholders. Take a closer look at SICC's potential here in our earnings growth report. Upon reviewing our latest valuation report, SICC's share price might be too optimistic. Key Takeaways Embark on your investment journey to our 589 Fast Growing Asian Companies With High Insider Ownership selection here. Ready For A Different Approach? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SEHK:6855 SHSE:603659 and SHSE:688234. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
22-07-2025
- Business
- Yahoo
Asian Growth Companies With High Insider Ownership In July 2025
As of July 2025, Asian markets are navigating a complex landscape marked by China's steady yet cautious economic growth and Japan's political uncertainties ahead of its Upper House election. In this environment, companies with high insider ownership can offer a unique advantage, as such ownership often aligns management interests with those of shareholders, potentially fostering resilience and strategic growth amid fluctuating market conditions. Top 10 Growth Companies With High Insider Ownership In Asia Name Insider Ownership Earnings Growth Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 61% Vuno (KOSDAQ:A338220) 15.6% 109.8% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Shanghai Huace Navigation Technology (SZSE:300627) 24.3% 23.5% Oscotec (KOSDAQ:A039200) 12.7% 98.7% Novoray (SHSE:688300) 23.6% 28.2% M31 Technology (TPEX:6643) 30.8% 63.4% Laopu Gold (SEHK:6181) 35.5% 42.6% Gold Circuit Electronics (TWSE:2368) 31.4% 25.9% Fulin Precision (SZSE:300432) 13.6% 43.7% Click here to see the full list of 589 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Below we spotlight a couple of our favorites from our exclusive screener. TaewoongLtd Simply Wall St Growth Rating: ★★★★☆☆ Overview: Taewoong Co., Ltd is a company that manufactures and sells open-die forgings and ring rolled products both in South Korea and internationally, with a market cap of approximately ₩863.32 billion. Operations: Revenue Segments (in millions of ₩): Insider Ownership: 21.7% Taewoong Ltd. is forecast to achieve significant earnings growth of 42.1% annually, outpacing the Korean market's 20.9%. Revenue growth is projected at 15.5% per year, surpassing the market average of 6.7%. Despite a low future Return on Equity of 8.3%, the stock trades at a substantial discount to its estimated fair value and has no recent insider trading activity, though its share price has been highly volatile recently. Take a closer look at TaewoongLtd's potential here in our earnings growth report. The valuation report we've compiled suggests that TaewoongLtd's current price could be inflated. Sunwoda ElectronicLtd Simply Wall St Growth Rating: ★★★★☆☆ Overview: Sunwoda Electronic Co., Ltd focuses on the research, development, design, production, and sale of lithium-ion battery modules and has a market cap of CN¥38.55 billion. Operations: Sunwoda Electronic Co., Ltd's revenue is primarily derived from its activities in the research, development, design, production, and sale of lithium-ion battery modules. Insider Ownership: 28.4% Sunwoda Electronic Ltd. is projected to achieve significant earnings growth of 25.6% annually, exceeding the Chinese market's 23.4%. Trading at a substantial discount to its estimated fair value, it offers good relative value compared to peers and industry standards. Despite low future Return on Equity forecasts and limited recent insider trading activity, Sunwoda's revenue growth of 16.5% per year outpaces the market average, supported by strategic moves like potential H-share issuance in Hong Kong. Get an in-depth perspective on Sunwoda ElectronicLtd's performance by reading our analyst estimates report here. Our valuation report unveils the possibility Sunwoda ElectronicLtd's shares may be trading at a discount. Shin Zu Shing Simply Wall St Growth Rating: ★★★★★☆ Overview: Shin Zu Shing Co., Ltd. operates in Taiwan, Singapore, and China, focusing on the research, design, development, production, assembly, testing, manufacturing, and trading of precision springs and various metal components with a market capitalization of approximately NT$46.40 billion. Operations: The company's revenue segments include Pivot products generating NT$12.82 billion, MIM Products with NT$120.91 million, and Turning and Milling Products at NT$119.20 million. Insider Ownership: 21.2% Shin Zu Shing is set for substantial growth, with earnings forecasted to rise by 34.8% annually, outpacing Taiwan's market average. Revenue is also expected to grow significantly at 31.4% per year. Despite recent volatility in its share price and a low projected Return on Equity of 12.3%, insider ownership remains strong with no significant insider trading activity noted recently, reflecting confidence in the company's strategic direction amidst board changes and corporate amendments. Dive into the specifics of Shin Zu Shing here with our thorough growth forecast report. According our valuation report, there's an indication that Shin Zu Shing's share price might be on the expensive side. Where To Now? Discover the full array of 589 Fast Growing Asian Companies With High Insider Ownership right here. Seeking Other Investments? The end of cancer? These 25 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include KOSDAQ:A044490 SZSE:300207 and TWSE:3376. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
16-07-2025
- Business
- Yahoo
3 Asian Growth Companies With High Insider Ownership And 58% Earnings Growth
In the current global market landscape, Asian economies are navigating a complex environment marked by trade tensions and mixed economic signals. Amid these challenges, growth companies with high insider ownership can offer unique insights into potential resilience and confidence in their business models. Name Insider Ownership Earnings Growth Zhejiang Leapmotor Technology (SEHK:9863) 15.6% 60.6% Techwing (KOSDAQ:A089030) 18.8% 68% Suzhou Sunmun Technology (SZSE:300522) 35.4% 77.7% Sineng ElectricLtd (SZSE:300827) 36% 25.8% Shanghai Huace Navigation Technology (SZSE:300627) 24.3% 23.5% Samyang Foods (KOSE:A003230) 11.7% 25.7% Oscotec (KOSDAQ:A039200) 12.7% 98.7% Novoray (SHSE:688300) 23.6% 28.2% Laopu Gold (SEHK:6181) 35.5% 42.3% Fulin Precision (SZSE:300432) 13.6% 43.7% Click here to see the full list of 603 stocks from our Fast Growing Asian Companies With High Insider Ownership screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★☆☆ Overview: China Ruyi Holdings Limited is an investment holding company involved in content production and online streaming across Mainland China, Hong Kong, Europe, and other international markets with a market cap of HK$51.53 billion. Operations: The company's revenue primarily comes from its content production business, which generated CN¥127.04 million, and its online streaming and gaming businesses, which brought in CN¥3.51 billion. Insider Ownership: 16.9% Earnings Growth Forecast: 48.7% p.a. China Ruyi Holdings, with significant insider ownership, is forecast to achieve above-market revenue growth of 17.7% annually, surpassing the Hong Kong market's 8.1%. Despite past shareholder dilution, the company is expected to become profitable within three years and its earnings are projected to grow at 48.65% per year. Recent events include participation in the Macquarie Asia Conference and an upcoming AGM addressing financial statements and director elections on June 3, 2025. Dive into the specifics of China Ruyi Holdings here with our thorough growth forecast report. Upon reviewing our latest valuation report, China Ruyi Holdings' share price might be too optimistic. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Kingdee International Software Group Company Limited is an investment holding company that operates in the enterprise resource planning sector, with a market capitalization of approximately HK$58.70 billion. Operations: The company generates revenue from its ERP Business, amounting to CN¥1.15 billion, and its Cloud Services Business, contributing CN¥5.11 billion. Insider Ownership: 19.9% Earnings Growth Forecast: 41.6% p.a. Kingdee International Software Group, characterized by high insider ownership, is projected to outpace the Hong Kong market with a revenue growth of 13.6% annually. The company is anticipated to transition to profitability within three years, with earnings expected to grow significantly at 41.56% per year. Despite a forecasted low return on equity of 7.6%, Kingdee trades at 35.5% below its estimated fair value, suggesting potential undervaluation in the market context. Click here to discover the nuances of Kingdee International Software Group with our detailed analytical future growth report. The analysis detailed in our Kingdee International Software Group valuation report hints at an deflated share price compared to its estimated value. Simply Wall St Growth Rating: ★★★★★★ Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacture, and commercialization of antibody drugs globally, with a market cap of HK$108.34 billion. Operations: The company's revenue primarily comes from the research, development, production, and sale of biopharmaceutical products, totaling CN¥2.12 billion. Insider Ownership: 18.9% Earnings Growth Forecast: 58.5% p.a. Akeso, with significant insider ownership, is positioned for robust growth in Asia's biopharmaceutical sector. The company is forecast to achieve a remarkable revenue increase of 29.8% annually and transition to profitability within three years. Recent advancements include the U.S. FDA approval of its PD-1 monoclonal antibody, penpulimab-kcqx, and promising clinical trial outcomes for its bispecific antibodies, enhancing Akeso's global leadership in cancer immunotherapy innovation and expanding its therapeutic portfolio beyond oncology. Delve into the full analysis future growth report here for a deeper understanding of Akeso. Our expertly prepared valuation report Akeso implies its share price may be too high. Delve into our full catalog of 603 Fast Growing Asian Companies With High Insider Ownership here. Ready To Venture Into Other Investment Styles? Uncover 13 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include SEHK:136 SEHK:268 and SEHK:9926. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data
